Topical adapalene cream 0.1% v/s isotretinoin 0.05% in the treatment of acne vulgaris: a randomized open-label clinical trial
Keywords:
Acne vulgaris, adapalene, isotretinoinAbstract
Background Acne is a common problem in adolescents and young adults. The disease and its associated problems with self-esteem and social inhibition represent a figurative "rite of passage" for as many as 80 percent of adolescents and young adults. Topical retinoids such as tretinoin, isotretinoin or adapalene are effective in many patients with comedonal acne. Objective To compare the efficacy and tolerability of adapalene cream 0.1% and isotretinoin gel 0.05% in the treatment of acne vulgaris of the face. Patients and methods This randomized open-label clinical trial was conducted at Baqai Medical University (BMU) and Skin Cure Centre (SCC), Karachi. 80 subjects were inducted in the study and were divided in two groups comprising of forty each in a group. First group was treated with adapalene cream 0.1% and the second one was treated with isotretinoin gel 0.05% for six weeks. Results Both adapalene and isotretinoin demonstrated comparable efficacy. However, significantly lower skin irritation was noted with adapalene. Conclusion Adapalene is an effective and safe treatment of acne vulgaris. However it causes less irritation than isotretinoin.References
Russell JJ. Topical therapy for acne. Am Fam Physician 2000; 61: 357-66.Toyoda M, Morohashi M. Pathogenesis of acne. Med Electron Microsc 2001; 34: 29-40.
Halder RM, Richards GM. Topical agents used in the management of hyperpigmentation. Skin Therapy Lett 2004; 9: 1-3.
Haider A, Shaw JC. Treatment of acne vulgaris. JAMA 2004; 292: 726-35.
Waugh J, Noble S, Scott LJ. Adapalene: a review of its use in the treatment of acne vulgaris. Drugs 2004; 64: 1465-78.
Ioannides D, Rigopoulos D, Katsambas A. Topical adapalene gel 0.1% vs. isotretinoin gel 0.05% in the treatment of acne vulgaris: a randomized open-label clinical trial. Br J Dermatol 2002; 147: 523-7.
Thiboutot D, Gold MH, Jarratt MT et al. Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris. Cutis 2001; 68 (4 Suppl): 10-9.
Cunliffe WJ, Danby FW, Dunlap F et al. Randomised, controlled trial of the efficacy and safety of adapalene gel 0.1% and tretinoin cream 0.05% in patients with acne vulgaris. Eur J Dermatol 2002; 12: 350-4.
Egan N, Loesche MC, Baker MM. Randomized, controlled, bilateral (split face) comparison trial of the tolerability and patient preference of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris. Cutis 2001; 68 (4 Suppl): 20-4.
